ABCB5(+) stem cells for treating ocular disease
US11129854B2 · kind B2 · utility
3Cited by
26References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 30, 2017 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | Jul 18, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Various aspects and embodiments of the present invention are directed to methods of treating a subject having an ocular condition, methods of isolating ocular stem cells, methods of selecting and/or producing ocular grafts for transplantation, and methods of promoting ocular cell regeneration as well as to grafts and preparations containing isolated ocular stem cells characterized by the expression of ABCB5 on their cell surface.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.